# Triana Biomedicines, Inc. — Form D

Triana Biomedicines, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-11. The offering totals $80.0M, of which $34.8M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-02-11
- Form: D
- Accession: 0001815337-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $80.0M
- Amount sold: $34.8M
- Remaining: $45.2M
- Investors: 12
- Date of first sale: 2022-01-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-433414

## Issuer

- Name: Triana Biomedicines, Inc.
- CIK: 0001815337
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1050 WALTHAM STREET, LEXINGTON, MA, 02421
- Phone: 781-317-4414

## Officers, directors & promoters (15)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Levin | Director | BOSTON, MA |
| Christopher O'Donnell | Director | Kingston, RI |
| Patrick Trojer | Director | Lexington, MA |
| Patrick Trojer | Executive Officer | Lexington, MA |
| Joshua Resnick | Director | New York, NY |
| Jigar Raythatha | Director | Boston, MA |
| David Grayzel | Director | Cambridge, MA |
| Andrew Hedin | Director | Claymont, DE |
| Lorence Kim | Director | Lexington, MA |
| Shelley Chu | Director | Lexington, MA |
| MILIND DESHPANDE | Director | WALTHAM, MA |
| MILIND DESHPANDE | Executive Officer | WALTHAM, MA |
| Simon Read | Director | Waltham, MA |
| Christopher O'Donnel | Director | Waltham, MA |
| Nathaniel Brooks Horwitz | Director | Boston, MA |

## Other filings by this issuer (4)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-12-04](https://search.stillhousedata.com/formd/0001815337-25-000003) | D | $120.1M | $120.1M |
| [2022-04-19](https://search.stillhousedata.com/formd/0001815337-22-000004) | D/A | $85.1M | $42.6M |
| [2021-09-17](https://search.stillhousedata.com/formd/0001815337-21-000001) | D | $10.0M | $10.0M |
| [2020-07-06](https://search.stillhousedata.com/formd/0001815337-20-000001) | D | $14.0M | $6.0M |

## More

- [CIK 1815337 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1815337&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001815337-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.